KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Operating Income (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed Operating Income for 17 consecutive years, with $20.1 billion as the latest value for Q4 2025.

  • Quarterly Operating Income rose 5.65% to $20.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $39.9 billion through Dec 2025, up 9.66% year-over-year, with the annual reading at $39.9 billion for FY2025, 9.66% up from the prior year.
  • Operating Income hit $20.1 billion in Q4 2025 for Johnson & Johnson, up from $7.0 billion in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $20.1 billion in Q4 2025 to a low of $3.9 billion in Q3 2022.
  • Historically, Operating Income has averaged $7.2 billion across 5 years, with a median of $6.0 billion in 2024.
  • Biggest five-year swings in Operating Income: plummeted 55.76% in 2023 and later surged 346.72% in 2024.
  • Year by year, Operating Income stood at $6.6 billion in 2021, then dropped by 19.79% to $5.3 billion in 2022, then fell by 19.78% to $4.3 billion in 2023, then soared by 346.72% to $19.0 billion in 2024, then rose by 5.65% to $20.1 billion in 2025.
  • Business Quant data shows Operating Income for JNJ at $20.1 billion in Q4 2025, $7.0 billion in Q3 2025, and $6.6 billion in Q2 2025.